Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yara Abdulrahman Alali"'
Autor:
Rinad Rasheed M. Alrashidi, Ohoud Abdullah Almutari, Badaya Awadh M. Alshehri, Rawan Ahmed H. Alshehri, Amal Abutaleb M. Qaysi, Mona Awad O. Al Balawi, Rawan Hamdi Bedaiwi, Rahf Mohammed I. Alqarni, Yara Abdulrahman Alali, Ahlam Shary J. Hazazi, Ibtisam Shary J. Hazazi, Alanoud Abdullah Alharbi, Ashwaq Nafea O. Alanazi, Rawan Hamoud M. Alatawi, Mohammed Hussen Sheikh
Publikováno v:
Journal of Pharmaceutical Research International. :249-254
Favism is most common in those who have G6PD deficiency from the Mediterranean region. As hemolytic anaemia is the most common complication of G6PD deficiency, and it can be life-threatening in certain people. Infection, hyperglycemia, certain meals,
Autor:
Khaled Nasser Almujel, Sultan Suliman Q. Al-Ruwaili, Ahmed Mohammed A. kaseb, Yousef Ali Alaenzi, Hussain Mubarak Huraysi, Faris Abdullah Alhashem, Yara Abdulrahman Alali, Meshal Ali Alruwaili, S. Aldawood, Abdalah Emad Almhmd
Publikováno v:
Journal of Pharmaceutical Research International. :120-125
Urethral stricture disease is a moderately frequent condition that comes at a high financial cost and can have long-term consequences. Understanding urethral stricture epidemiology is critical for identifying risk factors linked with illness genesis
Autor:
Maisaa Mokhtar M. Yousuf, Atheer Mansour E. Alatawi, Yara Abdulrahman Alali, Nouf Ali Alatawi, Ibtisam Shary J. Hazazi, Nujud Abdulqader Albalawi, Dimah Mohammed A. Abu Murad, Ahlam Shary J. Hazazi, Rahf Mohammed I. Alqarni, Badaya Awadh M. Alshehri
Publikováno v:
Journal of Pharmaceutical Research International. :139-147
Juvenile idiopathic arthritis (JIA) is a broad term that refers to a clinically heterogeneous group of arthritis that develops before the age of 16 and has no recognized cause. JIA treatment has evolved during the last two decades. Clinical trials re
Autor:
Khaled Nasser Almujel, Hussain Mubarak Huraysi, Faris Abdullah Alhashem, Abdalah Emad Almhmd, Ahmed Mohammed A. kaseb, S. Aldawood, Yara Abdulrahman Alali, Sultan Suliman Q. Al-Ruwaili, Meshal Ali Alruwaili, Yousef Ali Alaenzi
Publikováno v:
Current Aspects in Pharmaceutical Research and Development Vol. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2364f6604b5d9e0bdfa10cfc9df31250
https://doi.org/10.9734/bpi/caprd/v5/15044d
https://doi.org/10.9734/bpi/caprd/v5/15044d